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Medications That Should Not Be Crushed 
 
*Please note that this table provides a list of many common medications that should not be crushed,  
yet there are many more not listed.  The considerations presented in the narrative portion of this document will 
assist the healthcare professional in determining what other medications should not be crushed.*  
 
Generic Name Brand Name Dosage Form 
Sustained-release Medications1-5 
Acamprosate Campral Tablet 
Acetaminophen Tylenol Arthritis Pain 
Extended Relief 
Tablet 
Acetazolamide Diamox Sequels Capsule 
Albuterol VoSpire ER Tablet 
Alprazolam Xanax XR Tablet 
Amoxicillin/Clavulanate Augmentin XR Tablet 
Aspirin ZORprin Tablet 
Aspirin/Dipyridamole Aggrenox Capsule 
Belladonna Alkaloids Donnatal Extentabs Tablet 
Bisacodyl Fleet Bisacodyl, Modane Tablet 
Bupropion Wellbutrin SR, XL, Zyban Tablet 
Carbamazepine Carbatrol Capsule 
Carbamazepine Tegretol-XR Tablet 
Chlorpheniramine Maleate Chlor-Trimeton Allergy SR Tablet 
Ciprofloxacin Cipro XR Tablet 
Clarithromycin Biaxin XL Tablet 
Colestipol Colestid Tablet 
Dexmethylphenidate Focalin XR Capsule 
Dextroamphetamine/Amphetamine Adderall XR Capsule 
Diclofenac Voltaren-XR Tablet 
Diclofenac/Misoprostol Arthrotec Tablet 
Didanosine Videx EC Capsule 
Diltiazem Cardizem CD, Cartia XT, 
Dilacor XR, Diltia XT, Dilt 
XR, Taztia XT, Tiazac 
Capsule 
Diltiazem Cardizem LA Tablet 
Disopyramide Norpace CR Capsule 
Divalproex Depakote Sprinkle Capsule 
Divalproex Depakote, Depakote ER Tablet 
Doxycycline Doryx Tablet 
Duloxetine Cymbalta Capsule 
Enalapril/Felodipine Lexxel Tablet 
Erythromycin ERYC Capsule 
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Generic Name Brand Name Dosage Form 
Sustained-release Medications, continued 
Erythromycin Ery-Tab, PCE Dispertab Tablet 
Esomeprazole Nexium Capsule 
Felodipine Plendil Tablet 
Ferrous Sulfate Slow FE Tablet 
Fexofenadine/Pseudoephedrine Allegra-D Tablet 
Fluoxetine  ProzacWeekly Capsule 
Fluvastatin Lescol XL  Tablet 
Glipizide Glucotrol XL Tablet 
Hyoscyamine  Cystospaz-M, Levsinex 
Timecaps 
Capsule 
Hyoscyamine  Levbid Tablet 
Indomethacin Indocin SR Capsule 
Isosorbide Dinitrate Dilatrate-SR Capsule 
Isosorbide Mononitrate Imdur Tablet 
Isradipine DynaCirc CR Tablet 
Lansoprazole Prevacid Capsule 
Lansoprazole Prevacid SoluTab Tablet 
Levodopa/Carbidopa Sinemet CR Tablet 
Lithium Carbonate Eskalith CR, Lithobid Tablet 
Loratadine/Pseudoephedrine Claritin-D, Claritin-D 12 
Hour 
Tablet 
Lovastatin/Niacin Advicor Tablet 
Magnesium Slow-Mag Tablet 
Mesalamine Pentasa Capsule 
Mesalamine Asacol Tablet 
Metformin Fortamet, Glucophage XR Tablet 
Methylphenidate Metadate CD, Ritalin LA Capsule 
Methylphenidate Concerta, Metadate ER, 
Ritalin SR 
Tablet 
Metoprolol Toprol XL Tablet 
Metronidazole Flagyl ER Tablet 
Morphine Sulfate Avinza, Kadian Capsule 
Morphine Sulfate MS Contin, Oramorph SR Tablet 
Naproxen EC Naprosyn, Naprelan Tablet 
Niacin Niaspan, Slo-Niacin Tablet 
Nicardipine Cardene SR Capsule 
Nifedipine Adalat CC, Procardia XL Tablet 
Nisoldipine Sular Tablet 
Omeprazole Prilosec Capsule 
Omeprazole Prilosec OTC Tablet 
Oxybutynin Ditropan XL Tablet 
Oxycodone OxyContin Tablet 
Pantoprazole Protonix Tablet 
Paroxetine Paxil CR Tablet 
Pentoxifylline Trental Tablet 
Phendimetrazine Bontril Capsule 
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Generic Name Brand Name Dosage Form 
Sustained-release Medications, continued 
Phentermine Ionamin Capsule 
Phenylephrine/Brompheniramine Bromfed PD Capsule 
Phenylephrine/Guaifenesin Entex ER, LA, others Capsule 
Phenylephrine/Guaifenesin Liquibid D, others Tablet 
Potassium Chloride Micro-K, others Capsule 
Potassium Chloride K-Dur, Kaon-CL, Klor-
Con, others 
Tablet 
Procainamide Procanbid, Pronestyl SR Tablet 
Propafenone Rythmol SR Capsule 
Propranolol Inderal LA, InnoPran XL Capsule 
Pseudoephedrine Sudafed 12 Hour, 24 Hour Tablet 
Pseudoephedrine/Brompheniramine Bromfenex PD, Brovex SR, 
Iofed PD, others 
Capsule 
Pseudoephedrine/Carbinoxamine Coldec D, Rondec-TR, 
others 
Tablet 
Pseudoephedrine/Chlorpheniramine Deconamine SR  Capsule 
Pseudoephedrine/Chlorpheniramine Chlor-Trimeton Allergy 
Decongestant SR 
Tablet 
Pseudoephedrine/Dexbrompheniramine Disophrol, Drixoral Tablet 
Pseudoephedrine/Guaifenesin Entex PSE Capsule 
Pseudoephedrine/Guaifenesin Mucinex D Tablet 
Pyridostigmine Mestinon Timespan Tablet 
Rabeprazole AcipHex Tablet 
Theophylline Theo-24 Capsule 
Theophylline Theochron, Uniphyl Tablet 
Tolterodine Detrol LA Capsule 
Venlafaxine Effexor XR Capsule 
Verapamil Verelan SR, PM Capsule 
Verapamil Calan SR, Covera-HS, 
Isoptin SR 
Tablet 
Zolpidem Ambien CR Tablet 
Enteric-coated Medications1-5 
Aspirin Easprin, Ecotrin, others Tablet 
Bisacodyl Dulcolax Tablet 
Budesonide Entocort EC Capsule 
Diclofenac/Misoprostol Arthrotec Tablet 
Dirithromycin Dynabac Tablet 
Divalproex Depakote Tablet 
Ferrous Gluconate Fergon Tablet 
Ferrous Sulfate Feosol Tablet 
Lansoprazole Prevacid Suspension Particles 
Naproxen EC-Naprosyn Tablet 
Pancrelipase Creon, Lipram, Pancrease, 
Pancrease M, Pancrecarb 
MS, Ultrase MT, others 
 
 
Capsule 
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Generic Name Brand Name Dosage Form 
Enteric-coated Medications, continued 
Sulfasalazine Azulfidine En-Tabs Tablet 
Tamsulosin Flomax Capsule 
Medications With Poor Taste1-5 
Carbenicillin Geocillin Tablet 
Cefuroxime Ceftin Tablet 
Ciprofloxacin Cipro Tablet 
Docusate Sodium Colace Capsule 
Eszopiclone Lunesta Tablet 
Ibuprofen Motrin, Advil Tablet 
Imatinib Gleevec Tablet 
Indinavir Crixivan Capsule 
Penicillin Betapen-VK Tablet 
Praziquantel Biltricide Tablet 
Promethazine Phenergan Tablet 
Propoxyphene/Acetaminophen Darvocet Tablet 
Raloxifene Evista Tablet 
Tetracycline Sumycin Tablet 
Topiramate Topamax Capsule/Tablet 
Trazodone Desyrel Tablet 
Medications That Can Be Irritating1-5 
Alendronate Fosamax Tablet 
Benzonatate Tessalon Perles Capsule 
Diflunisal Dolobid Tablet 
Ganciclovir Cytovene Capsule 
Isotretinoin Accutane Capsule 
Piroxicam Feldene Capsule 
Temozolomide Temodar Capsule 
Valproic Acid Depakene Capsule 
Medications That Can Be Teratogenic1-5 
Dutasteride Avodart Capsule 
Finasteride Propecia, Proscar Tablet 
Lenalidomide Revlimid Capsule 
Mycophenolate Cellcept Capsule/Tablet 
Ganciclovir Cytovene Capsule 
Valganciclovir Valcyte Tablet 
Ribavirin Copegus, Rebetol Tablet, Capsule 
 
 
Background 
There is a wide range of circumstances that 
make it either impractical or impossible to 
administer solid oral medications.  For example, 
some patients might need their medications to be 
given through a feeding tube, such as a 
nasogastric (NG) tube.  Some patients may have 
dysphagia (difficulty swallowing) due to the 
effects of age, stroke, chemotherapy, etc.  Other 
patients might have trouble swallowing due to 
impaired cough/gag reflexes or due to problems 
with oral secretions. 
An alternative way to provide medication is 
necessary for these types of patients.  Oral 
medications are frequently crushed to allow for 
better ease of administration; however, there are 
many solid oral medications that should not be 
crushed or broken.1,2 
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Types of Drug Formulations 
There are a variety of reasons why crushing or 
breaking some solid oral medications is not a 
good idea.  One is that this process can alter the 
pharmacokinetics of certain drug formulations.  
For example, sustained-release medications are 
designed to release the drug over an extended 
period of time, maintaining steady drug levels 
over 8, 12, or 24 hours.  These formulations 
usually either contain layers where drug is 
released as each layer is dissolved, pellets that 
dissolve at different time intervals, or inert 
matrixes that slowly release the drug over a period 
of time.  Crushing or breaking these formulations 
can ruin their sustained-release properties and can 
cause the patient to receive a large dose all at 
once.  This increases the risk of side effects and 
toxicity.  It also eliminates the benefits of giving a 
sustained-release formulation because the drug’s 
action will not last for the full dosing interval.1-3 
Sustained-release medications generally have 
an abbreviation attached to the brand name.  This 
abbreviation is a clue that crushing or breaking the 
medication might alter the formulation.  Examples 
of abbreviations include LA (long-acting), SR 
(slow- or sustained-release), CR (controlled-
release), CRT (controlled-release tablet), XL 
(extended-release), XR (extended-release), SA 
(sustained-action), TD (time-delay), TR (time-
release), and 24 (24-hour).  The words 
“Spansules,” “Sequels,” “Timecaps,” “Sprinkle,” 
etc., are also often added to the end of the brand 
name to signify a sustained-release product.1-3 
Another example of oral medications that 
should not be crushed is enteric-coated 
medications.  These medications are designed to 
remain intact as they pass through the stomach 
and not release the drug until the tablet reaches 
the intestines.  This formulation is frequently used 
for drugs that can be irritating to the stomach, for 
drugs that are destroyed by stomach acids, and to 
achieve a delayed onset of action.  Destroying the 
enteric coating of these medications can 
jeopardize the stability of the drug and its 
intended action, or increase the risk of side 
effects.  They also don’t pulverize well and can 
end up clogging tubes.1,3 
Some medications can irritate the oral mucosa 
and upper gastrointestinal tract, while others are 
bitter tasting, or can even stain the mouth and 
teeth.  Also, some medications have coatings to 
prevent drug absorption during handling because 
they are potentially carcinogenic.  Even though 
crushing or breaking these drugs may not affect 
their drug delivery mechanisms, it might cause 
aerosolization of drug particles.  This increases 
the risk of exposure to drug handlers or healthcare 
personnel and possible health risks.1 
Sublingual or buccal tablets are placed under 
the tongue or between the gum and cheek.  These 
formulations are designed to dissolve and release 
medication for rapid absorption by the large 
supply of blood vessels in the mouth.  Swallowing 
or chewing these formulations might cause them 
to not be effective, or to be less effective.1,2 
 
Alternatives to Crushing 
Alternatives to crushing are available for many 
medications on the market today.  Some may be 
given in ways other than being swallowed whole.  
For example, some capsules can be opened and 
the contents sprinkled on soft food such as 
applesauce or pudding.  If the capsule is a 
sustained-release formulation, be careful that the 
patient doesn’t chew the pellets.  Other capsules 
contain a liquid, which can be removed and 
administered.  Some medications are already 
conveniently supplied in a liquid formulation.  If 
there is not a liquid formulation commercially 
available, it may be possible to compound one.1-3 
Sometimes, the injectable form of a drug can 
be used by placing the appropriate amount of 
injectable solution into an appropriate fluid such 
as water or juice.  However, it is necessary to 
make certain that there are no problems with 
compatibility or changes in drug absorption before 
doing this.  Another possible option is to use a 
chemically different but clinically similar drug 
that is available in liquid form.1 
 
Other Considerations 
Whenever medications must be administered 
to patients with enteral feeding tubes, special 
considerations must be recognized.  These 
considerations include the type of feeding tube, 
the tubing bore, its placement site, the drug 
absorption site, the time necessary for drug 
absorption, physical or chemical incompatibilities 
of the drug or drugs 
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to be administered with feeding formula, other 
administered drugs, and tube-flushing solution.  
Some of the small-bore tubes include nasoenteric 
(NE) tubes which can be placed into the stomach, 
duodenum, or jejunum.  Needle catheter 
jejunostomy (NCJ) tubes are very small-bore 
tubes that are surgically inserted into the jejunum.  
Only liquid dosage forms should be placed in NE 
tubes and drug administration into a NCJ tube 
should be avoided whenever possible due to 
clogging.  Large-bore tubes present less risk for 
clogging.  These large-bore tubes include 
nasogastric (NG) and orogastric (OG) tubes as 
well as tubes that are surgically inserted across the 
abdominal wall using open, laparoscopic, 
endoscopic, or fluoroscopic techniques.  
Gastrostomy (G) tubes and jejunostomy (J) tubes 
are included in this group.  More information on 
drug therapy administration in patients with 
enteral feeding tubes can be found in an article by 
Beckwith et al.6 
 
Conclusion 
There are frequent circumstances where 
patients are unable to swallow solid oral 
medications whole, making it necessary to find a 
suitable alternative for administration.  Watch for 
medications that should not be crushed or broken 
because of the risk of destroying the drug delivery 
mechanism, or exposing the patient or handler to 
potentially irritating or harmful compounds.  
When considering the alternatives available, it is 
important to remember that substituting other 
formulations of the same medication might 
require a change in the dosing regimen, 
particularly for sustained-release medications.  
The tables identify some medications that should 
not be crushed.  Keep in mind that the examples 
listed are commonly used drugs and are 
representative of drugs that should not be crushed 
or broken, but they do not make up a complete 
list.1 
 
 
 
Users of this document are cautioned to use their own 
professional judgment and consult any other necessary 
or appropriate sources prior to making clinical 
judgments based on the content of this document.  Our 
editors have researched the information with input 
from experts, government agencies, and national 
organizations.  Information and Internet links in this 
article were current as of the date of publication. 
 
Project Leaders in preparation of this Detail-
Document:  Kay Shaver, Pharm.D., and Joseph 
A. Woelfel, Ph.D., FASCP, R.Ph., Assistant Editor 
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